MSH2 and adenocarcinoma: The combined frequency of HGD and adenocarcinoma was 35% in WT, 45% in Msh2-KO, and 63% in p53-KO mice [11]. Msh2-KO and p53-KO groups developed significantly more and larger tumors per mouse than the WT group [11].